Compound Radar

PACS Group, Inc. (PACS) Stock Analysis

Price $43.67
Market cap $6.91B
Next earnings Nov 9, 2026
Entry status Good Entry

Last updated Sep 8, 2026

Health Check

Last analyzed Sep 7, 2026

61
61/100 Good Quality
  • Financial Health 50
  • Profitability 80
  • Business Quality 60
  • Balance Sheet 15
  • Cash Flow 80

Why this rating?

Health 61/100 — Good Quality

Strongest Profitability 80/100
Softest Balance Sheet 15/100
Good Entry

A usable setup — not as clean as Strong Entry, but timing is not mixed or weak.

Company overview

PACS Group, Inc. (PACS) is a Medical Care Facilities company in the Healthcare sector. Compound Radar rates PACS Group, Inc. 61/100 (Good Quality) due to solid business quality, steady revenue growth, and elevated leverage.

Investment profile

  • Quality Moderate
  • Growth Moderate
  • Balance Sheet Stretched
  • Valuation Attractive

Financial highlights

Valuation

  • P/E 25.54
  • Forward P/E 16.09
  • PEG 1.07
  • EV/Revenue 1.8

Profitability

  • Revenue Growth 9.1%
  • Gross Margin 17.3%
  • Operating Margin 7.7%
  • Net Margin 4.8%
  • ROE 27.9%

Financial strength

  • Cash $164.45M
  • Debt $3.40B
  • Net Cash $-3.24B
  • Free Cash Flow $155.07M
  • Current Ratio 0.91

Similar companies

Peers in Medical Care Facilities, ranked by Financial Health.

Company Ticker
Price Current price

Latest quoted price for the name. Helps anchor the setup in today’s market level.

Health Entry

View all in Medical Care Facilities →

FAQ

How Compound Radar scores and tracks PACS Group, Inc. (PACS).

View Methodology & FAQ →